Literature DB >> 27797928

Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.

Ajenthen Ranjan1,2, Signe Schmidt3,2, Camilla Damm-Frydenberg3, Isabelle Steineck3,2, Trine Ryberg Clausen4, Jens Juul Holst5,6, Sten Madsbad3,5, Kirsten Nørgaard3.   

Abstract

OBJECTIVE: This study compared the ability of glucagon to restore plasma glucose (PG) after mild hypoglycemia in patients with type 1 diabetes on an isocaloric high-carbohydrate diet (HCD) versus a low-carbohydrate diet (LCD). RESEARCH DESIGN AND METHODS: Ten patients with insulin pump-treated type 1 diabetes randomly completed 1 week of the HCD (≥250 g/day) and 1 week of the LCD (≤50 g/day). After each week, mild hypoglycemia was induced by a subcutaneous insulin bolus in the fasting state. When PG reached 3.9 mmol/L, 100 µg glucagon was given subcutaneously, followed by 500 µg glucagon 2 h later.
RESULTS: Compared with the HCD, the LCD resulted in lower incremental rises in PG after the first (mean ± SEM: 1.3 ± 0.3 vs. 2.7 ± 0.4 mmol/L, P = 0.002) and second glucagon bolus (4.1 ± 0.2 vs. 5.6 ± 0.5 mmol/L, P = 0.002). No differences were observed between the diets regarding concentrations of insulin, glucagon, and triglycerides.
CONCLUSIONS: The LCD reduces the treatment effect of glucagon on mild hypoglycemia. Carbohydrate intake should be considered when low-dose glucagon is used to correct hypoglycemia.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797928     DOI: 10.2337/dc16-1472

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

Review 1.  Role of Glucagon in Automated Insulin Delivery.

Authors:  Leah M Wilson; Peter G Jacobs; Jessica R Castle
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12-10       Impact factor: 4.741

2.  Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.

Authors:  Isabelle I K Steineck; Ajenthen Ranjan; Signe Schmidt; Trine R Clausen; Jens J Holst; Kirsten Nørgaard
Journal:  Diabetologia       Date:  2019-01-14       Impact factor: 10.122

3.  Consuming a ketogenic diet leads to altered hypoglycemic counter-regulation in mice.

Authors:  Christopher D Morrison; Cristal M Hill; Marina A DuVall; Carolyn E Coulter; Jasmin L Gosey; Matthew J Herrera; Lauren E Maisano; Hunter X Sikaffy; David H McDougal
Journal:  J Diabetes Complications       Date:  2020-02-08       Impact factor: 2.852

4.  The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

Authors:  Christina Pedersen; Guillaume Kraft; Dale S Edgerton; Melanie Scott; Ben Farmer; Marta Smith; David C Laneve; Phillip E Williams; L Merkle Moore; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-03-24       Impact factor: 4.310

5.  A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia.

Authors:  Christopher M Mulla; Stamatina Zavitsanou; Alejandro Jose Laguna Sanz; David Pober; Lauren Richardson; Pamela Walcott; Ipsa Arora; Brett Newswanger; Martin J Cummins; Steve J Prestrelski; Francis J Doyle; Eyal Dassau; Mary Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 6.  Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions.

Authors:  Dessi P Zaharieva; Ananta Addala; Kimber M Simmons; David M Maahs
Journal:  Curr Obes Rep       Date:  2020-10-27

7.  Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats.

Authors:  Christina Pedersen; Stephan D Bouman; Trine Porsgaard; Mette M Rosenkilde; Nikolaj K Roed
Journal:  Physiol Rep       Date:  2018-03

Review 8.  Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?

Authors:  Sam N Scott; Lorraine Anderson; James P Morton; Anton J M Wagenmakers; Michael C Riddell
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

Review 9.  New uses and formulations of glucagon for hypoglycaemia.

Authors:  Pilar I Beato-Víbora; Francisco J Arroyo-Díez
Journal:  Drugs Context       Date:  2019-07-30

Review 10.  Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.

Authors:  Nuria Vilarrasa; Patricia San Jose; Miguel Ángel Rubio; Albert Lecube
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-21       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.